mRNA Technology - Search News

FDA to review Moderna's mRNA flu vaccine

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

The FDA is slated to make a decision on the flu shot on Aug. 5, which will allow Moderna to make the vaccine available for the upcoming influenza season.

· 57m

FDA agrees to review Moderna mRNA flu vaccine after initial refusal-to-file

Scientific American · 7d

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

BioSpace

Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus

Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

Yahoo

How RFK Jr.’s misguided science on mRNA vaccines is shaping policy

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA to review Moderna's mRNA flu vaccine

Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus

How RFK Jr.’s misguided science on mRNA vaccines is shaping policy

Trending now